119 related articles for article (PubMed ID: 28418872)
1. Overexpression of Fli-1 in astrocytoma is associated with poor prognosis.
Tsai HP; Tsai TH; Hsieh YJ; Chen YT; Lee CL; Tsai YC; She TC; Lin CL; Chai CY; Kwan AL
Oncotarget; 2017 Apr; 8(17):29174-29186. PubMed ID: 28418872
[TBL] [Abstract][Full Text] [Related]
2. High-level Sp1 is Associated with Proliferation, Invasion, and Poor Prognosis in Astrocytoma.
Chen YT; Tsai HP; Wu CC; Chen CY; Chai CY; Kwan AL
Pathol Oncol Res; 2019 Jul; 25(3):1003-1013. PubMed ID: 29948615
[TBL] [Abstract][Full Text] [Related]
3. Increased FLI-1 Expression is Associated With Poor Prognosis in Non-Small Cell Lung Cancers.
Lin SF; Wu CC; Chai CY
Appl Immunohistochem Mol Morphol; 2016 Sep; 24(8):556-61. PubMed ID: 26317314
[TBL] [Abstract][Full Text] [Related]
4. Oncogenic Fli-1 is a potential prognostic marker for the progression of epithelial ovarian cancer.
Song W; Hu L; Li W; Wang G; Li Y; Yan L; Li A; Cui J
BMC Cancer; 2014 Jun; 14():424. PubMed ID: 24923303
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of Fli-1 is associated with adverse prognosis of endometrial cancer.
Song W; Zhang T; Li W; Mu R; Zhang L; Li Y; Jin B; Wang N; Li A; Cui J
Cancer Invest; 2015; 33(9):469-75. PubMed ID: 26305602
[TBL] [Abstract][Full Text] [Related]
6. Region-Specific Dok2 Overexpression Associates with Poor Prognosis in Human Astrocytoma.
Deshpande RP; Chandra Sekhar YBVK; Panigrahi M; Babu PP
Mol Neurobiol; 2018 Jan; 55(1):402-408. PubMed ID: 27975172
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-144 suppresses tumorigenesis and tumor progression of astrocytoma by targeting EZH2.
Lin L; Zheng Y; Tu Y; Wang Z; Liu H; Lu X; Xu L; Yuan J
Hum Pathol; 2015 Jul; 46(7):971-80. PubMed ID: 25907866
[TBL] [Abstract][Full Text] [Related]
8. Expression of targeting protein for Xenopus kinesin-like protein 2 is associated with progression of human malignant astrocytoma.
Li B; Qi XQ; Chen X; Huang X; Liu GY; Chen HR; Huang CG; Luo C; Lu YC
Brain Res; 2010 Sep; 1352():200-7. PubMed ID: 20599806
[TBL] [Abstract][Full Text] [Related]
9. Vascular endothelial growth factor expression and vascular density as prognostic markers of survival in patients with low-grade astrocytoma.
Abdulrauf SI; Edvardsen K; Ho KL; Yang XY; Rock JP; Rosenblum ML
J Neurosurg; 1998 Mar; 88(3):513-20. PubMed ID: 9488306
[TBL] [Abstract][Full Text] [Related]
10. Ewing's sarcoma fusion protein, EWS/Fli-1 and Fli-1 protein induce PLD2 but not PLD1 gene expression by binding to an ETS domain of 5' promoter.
Kikuchi R; Murakami M; Sobue S; Iwasaki T; Hagiwara K; Takagi A; Kojima T; Asano H; Suzuki M; Banno Y; Nozawa Y; Murate T
Oncogene; 2007 Mar; 26(12):1802-10. PubMed ID: 16964281
[TBL] [Abstract][Full Text] [Related]
11. Galectin-3 Mediates Tumor Progression in Astrocytoma by Regulating Glycogen Synthase Kinase-3β Activity.
Tsai HP; Lin CJ; Lieu AS; Chen YT; Tseng TT; Kwan AL; Loh JK
Curr Issues Mol Biol; 2023 Apr; 45(4):3591-3602. PubMed ID: 37185758
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of vascular adhesion protein-1 is associated with poor prognosis of astrocytomas.
Kostoro J; Chang SJ; Clark Lai YC; Wu CC; Chai CY; Kwan AL
APMIS; 2016 Jun; 124(6):462-8. PubMed ID: 26935340
[TBL] [Abstract][Full Text] [Related]
13. Elevated HOXA1 expression correlates with accelerated tumor cell proliferation and poor prognosis in gastric cancer partly via cyclin D1.
Yuan C; Zhu X; Han Y; Song C; Liu C; Lu S; Zhang M; Yu F; Peng Z; Zhou C
J Exp Clin Cancer Res; 2016 Jan; 35():15. PubMed ID: 26791264
[TBL] [Abstract][Full Text] [Related]
14. Prognostic impact of TP53 mutation status for adult patients with supratentorial World Health Organization Grade II astrocytoma or oligoastrocytoma: a long-term analysis.
Ständer M; Peraud A; Leroch B; Kreth FW
Cancer; 2004 Sep; 101(5):1028-35. PubMed ID: 15329912
[TBL] [Abstract][Full Text] [Related]
15. Nucleophosmin overexpression is associated with poor survival in astrocytoma.
Kuo YH; Chen YT; Tsai HP; Chai CY; Kwan AL
APMIS; 2015 Jun; 123(6):515-22. PubMed ID: 25907517
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic and prognostic significance of cyclin A expression in low-grade astrocytomas: comparison with astrogliosis and high-grade tumours.
Hara A; Saegusa M; Ichinoe M; Okayasu I
J Clin Pathol; 2008 Mar; 61(3):287-92. PubMed ID: 18156430
[TBL] [Abstract][Full Text] [Related]
17. Relationship between SATB1 expression and prognosis in astrocytoma.
Chu SH; Ma YB; Feng DF; Zhang H; Qiu JH; Zhu ZA; Li ZQ; Jiang PC
J Clin Neurosci; 2013 Apr; 20(4):543-7. PubMed ID: 23317753
[TBL] [Abstract][Full Text] [Related]
18. [Multivariate analysis of the parameters related to prognosis of astrocytoma].
Zhong D; Li X; Zhang G
Zhonghua Bing Li Xue Za Zhi; 2001 Oct; 30(5):345-9. PubMed ID: 11769730
[TBL] [Abstract][Full Text] [Related]
19. miR-137 acts as a tumor suppressor in astrocytoma by targeting RASGRF1.
Deng D; Xue L; Shao N; Qu H; Wang Q; Wang S; Xia X; Yang Y; Zhi F
Tumour Biol; 2016 Mar; 37(3):3331-40. PubMed ID: 26440052
[TBL] [Abstract][Full Text] [Related]
20. Human positive coactivator 4 (PC4) is involved in the progression and prognosis of astrocytoma.
Chen L; Du C; Wang L; Yang C; Zhang JR; Li N; Li Y; Xie XD; Gao GD
J Neurol Sci; 2014 Nov; 346(1-2):293-8. PubMed ID: 25262015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
